文献速递慢性静脉疾病静脉血栓栓塞

中枢神经肌肉疾病患者的髂股静脉支架置入

Iliofemoral venous stenting in patients with central neuromuscular disorders.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-10-22

回顾性分析2000至2020年间42例(45条肢体)中枢神经肌肉疾病患者因慢性髂股静脉阻塞接受支架置入的资料。支架置入后静脉临床严重程度评分、疼痛视觉模拟评分和水肿分级均呈改善趋势,但53%(24/45)的肢体需要再次干预。

要点

  • 中枢神经肌肉疾病患者保守治疗失败后可考虑髂股静脉支架置入以改善症状。
  • 支架置入后临床参数呈改善趋势,但需告知再干预率较高(53%)。
  • 血栓后与非血栓性髂静脉病变比例为3:1,多数患者CEAP分级≥C4。

核心结论

  • 静脉内支架置入与中枢神经肌肉疾病患者临床参数的改善相关。
  • 这类患者再干预率相对较高,需提前告知以纠正残留或复发症状。

研究设计与样本

  • 共纳入42例(45条肢体)已知中枢神经肌肉疾病、因慢性髂股静脉阻塞接受支架置入的患者。
  • 中枢神经肌肉疾病包括帕金森病(20条肢体)、多发性硬化(15条肢体)和其他神经肌肉疾病(10条肢体)。
  • 平均年龄59±14岁,血栓后与非血栓性髂静脉病变比例为3:1。

主要发现

  • 多数患者CEAP分级≥C4(64.4%),25条肢体有静脉血栓栓塞史(56%)。
  • 支架置入后静脉临床严重程度评分、疼痛视觉模拟评分和水肿分级均呈改善趋势。
  • 溃疡愈合率≤90%。
  • 45条肢体中24条(53%)在初始支架置入后需要某种形式的再干预。

临床怎么用

  • 对保守治疗失败的中枢神经肌肉疾病合并慢性髂股静脉阻塞患者,可考虑髂股静脉支架置入。
  • 术前应告知患者再干预率较高(53%),以管理预期。

局限性

  • 回顾性研究设计。
  • 样本量较小(42例/45条肢体)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Leg swelling in patients with various central neuromuscular disorders is a common clinical scenario and can lead to significant morbidity. The aim of the present study was to evaluate a subset of patients with central neuromuscular disorders who had undergone iliofemoral venous stenting at a specialty venous clinic at a tertiary care hospital. METHODS: From January 2000 to December 2020, the medical records of all patients with a known central neuromuscular disorder who had undergone iliofemoral venous stenting for chronic iliofemoral venous obstruction were retrospectively analyzed. RESULTS: A total of 42 patients (45 limbs) with central neuromuscular disorders had undergone iliofemoral stenting after failure of a trial of conservative therapy. The central neuromuscular disorders included Parkinson disease (n = 20 limbs), multiple sclerosis (n = 15 limbs), and other neuromuscular conditions (n = 10 limbs). The mean age of the sample was 59 ± 14 years. The ratio of post-thrombotic to nonthrombotic iliac vein lesions was 3:1. Most of the patients had had CEAP (clinical, etiologic, anatomic, pathophysiologic) class ≥C4 (64.4%); 25 limbs had a history of venous thromboembolism (56%). A trend was seen toward improvement in all clinical parameters measured (venous clinical severity score, visual analog scale for pain score, and edema grade) after stenting. An ulcer healing rate of ≤90% was noted after stenting. Of the 45 limbs, 24 had required some form of reintervention (53%) after initial stent placement. CONCLUSIONS: Venous intervention in the form of endovenous stenting was associated with improvement in the clinical parameters for patients with central neuromuscular disorders. However, these patients should be counseled regarding the relatively higher rate of reinterventions that might be required to correct residual or recurrent symptoms.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Saleem T, Powell T, Raju S, et al. Iliofemoral venous stenting in patients with central neuromuscular disorders. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34695594. doi:10.1016/j.jvsv.2021.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。